Diffusion radiomics analysis of intratumoral heterogeneity in a murine prostate cancer model following radiotherapy: Pixelwise correlation with histology

Journal of Magnetic Resonance Imaging

Volumn 46, Issue 2, 2017, Pages 483-489

  Lin, Yu Chun ^a,b   Lin, Gigin ^a   Hong, Ji Hong ^a,b   Lin, Yi Ping ^a   Chen, Fang Hsin ^a,b   Ng, Shu Hang ^a,b   Wang, Chun Chieh ^a,b  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^b CHANG GUNG UNIVERSITY   (Taiwan)

Author keywords

apparent diffusion coefficient; diffusion MRI; radiotherapy

Indexed keywords

TUMOR MARKER; BIOLOGICAL MARKER;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL IMAGING SYSTEM; ANIMAL MODEL; ANIMAL TISSUE; APPARENT DIFFUSION COEFFICIENT; ARTICLE; CANCER RADIOTHERAPY; CONTROLLED STUDY; CORRELATIONAL STUDY; CURVE FITTING; DIFFUSION WEIGHTED IMAGING; EXTRACELLULAR SPACE; HISTOLOGY; MALE; MOUSE; MURINE; NON INVASIVE PROCEDURE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SCANNER; NUCLEAR SIZE; PRIORITY JOURNAL; PROSTATE CANCER; RADIATION RESPONSE; TUMOR MICROENVIRONMENT; TUMOR MODEL; ALGORITHM; ANIMAL; BREATHING; C57BL MOUSE; CANCER TRANSPLANTATION; COMPUTER ASSISTED DIAGNOSIS; DIAGNOSTIC IMAGING; IMAGE PROCESSING; PROSTATE; PROSTATE TUMOR; REPRODUCIBILITY; SIGNAL PROCESSING; TRANSGENIC MOUSE; TUMOR CELL LINE;

ALGORITHMS; ANIMALS; BIOMARKERS; CELL LINE, TUMOR; DIFFUSION MAGNETIC RESONANCE IMAGING; IMAGE INTERPRETATION, COMPUTER-ASSISTED; IMAGE PROCESSING, COMPUTER-ASSISTED; MALE; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; NEOPLASM TRANSPLANTATION; PROSTATE; PROSTATIC NEOPLASMS; RADIOTHERAPY; REPRODUCIBILITY OF RESULTS; RESPIRATION; SIGNAL PROCESSING, COMPUTER-ASSISTED;

EID: 85012884931     PISSN: 10531807     EISSN: 15222586     Source Type: Journal    
DOI: 10.1002/jmri.25583     Document Type: Article

References (27)

1. Antunes J, Viswanath S, Rusu M, et al. Radiomics analysis on FLT-PET/MRI for characterization of early treatment response in renal cell carcinoma: a proof-of-concept study. Transl Oncol 2016;9:155–162.
2. van Rossum PS, van Lier AL, van Vulpen M, et al. Diffusion-weighted magnetic resonance imaging for the prediction of pathologic response to neoadjuvant chemoradiotherapy in esophageal cancer. Radiother Oncol 2015;115:163–170.
3. Kim TH, Jeong JY, Lee SW, et al. Diffusion-weighted magnetic resonance imaging for prediction of insignificant prostate cancer in potential candidates for active surveillance. Eur Radiol 2015;25:1786–1792.
4. Hotker AM, Mazaheri Y, Zheng J, et al. Prostate cancer: assessing the effects of androgen-deprivation therapy using quantitative diffusion-weighted and dynamic contrast-enhanced MRI. Eur Radiol 2015;25:2665–2672.
5. Liu L, Wu N, Ouyang H, Dai JR, Wang WH. Diffusion-weighted MRI in early assessment of tumour response to radiotherapy in high-risk prostate cancer. Br J Radiol 2014;87:20140359.
6. Donati OF, Afaq A, Vargas HA, et al. Prostate MRI: evaluating tumor volume and apparent diffusion coefficient as surrogate biomarkers for predicting tumor Gleason score. Clin Cancer Res 2014;20:3705–3711.
7. Gibbs P, Liney GP, Pickles MD, Zelhof B, Rodrigues G, Turnbull LW. Correlation of ADC and T2 measurements with cell density in prostate cancer at 3.0 Tesla. Invest Radiol 2009;44:572–576.
8. Bains LJ, Zweifel M, Thoeny HC. Therapy response with diffusion MRI: an update. Cancer Imaging 2012;12:395–402.
9. Lyng H, Haraldseth O, Rofstad EK. Measurement of cell density and necrotic fraction in human melanoma xenografts by diffusion weighted magnetic resonance imaging. Magn Reson Med 2000;43:828–836.
10. Chatterjee A, Watson G, Myint E, Sved P, McEntee M, Bourne R. Changes in epithelium, stroma, and lumen space correlate more strongly with Gleason pattern and are stronger predictors of prostate ADC changes than cellularity metrics. Radiology 2015;277:751–762.
11. Hill DK, Kim E, Teruel JR, et al. Diffusion-weighted MRI for early detection and characterization of prostate cancer in the transgenic adenocarcinoma of the mouse prostate model. J Magn Reson Imaging 2016;43:1207–1217.
12. Wang XZ, Wang B, Gao ZQ, et al. Diffusion-weighted imaging of prostate cancer: correlation between apparent diffusion coefficient values and tumor proliferation. J Magn Reson Imaging 2009;29:1360–1366.
13. Wang X, Qian Y, Liu B, et al. High-b-value diffusion-weighted MRI for the detection of prostate cancer at 3 T. Clin Radiol 2014;69:1165–1170.
14. Ueno Y, Kitajima K, Sugimura K, et al. Ultra-high b-value diffusion-weighted MRI for the detection of prostate cancer with 3-T MRI. J Magn Reson Imaging 2013;38:154–160.
15. de Perrot T, Scheffler M, Boto J, et al. Diffusion in prostate cancer detection on a 3T scanner: How many b-values are needed? J Magn Reson Imaging 2016;44:601–609.
16. Lin YC, Wang JJ, Hong JH, et al. Noninvasive monitoring of microvascular changes with partial irradiation using dynamic contrast-enhanced and blood oxygen level-dependent magnetic resonance imaging. Int J Radiat Oncol Biol Phys 2013;85:1367–1374.
17. Lin YC, Wang CC, Lin G, et al. A simple method to improve the quality of diffusion-weighted magnetic resonance imaging with rapid histologic correlation in a murine model. Mol Imaging 2014;13:1–8.
18. Le Bihan D, Johansen-Berg H. Diffusion MRI at 25: exploring brain tissue structure and function. Neuroimage 2012;61:324–341.
19. Iannelli G, Caivano R, Rago L, et al. Diffusion-weighted magnetic resonance imaging in patients with prostate cancer treated with radiotherapy. Tumori 2016;102:71–76.
20. Kobayashi M. The irradiation effects on the cytoskeletons of C3H/He mouse mammary tumor cells and vascular basement membrane in relation to vascular invasion: a model of intraoperative radiotherapy. Tohoku J Exp Med 1988;154:71–89.
21. Li X, Jiang H, Niu J, Zheng Y. Correlation of ADC value with pathologic indexes in colorectal tumor homografts in Balb/c mouse. Chin J Cancer Res 2014;26:444–450.
22. Koral K, Mathis D, Gimi B, et al. Common pediatric cerebellar tumors: correlation between cell densities and apparent diffusion coefficient metrics. Radiology 2013;268:532–537.
23. Weiss E, Ford JC, Olsen KM, et al. Apparent diffusion coefficient (ADC) change on repeated diffusion-weighted magnetic resonance imaging during radiochemotherapy for non-small cell lung cancer: A pilot study. Lung Cancer 2016;96:113–119.
24. Rashid F, Ul Haque A. Frequencies of different nuclear morphological features in prostate adenocarcinoma. Ann Diagn Pathol 2011;15:414–421.
25. Padhani AR, Liu G, Koh DM, et al. Diffusion-weighted magnetic resonance imaging as a cancer biomarker: consensus and recommendations. Neoplasia 2009;11:102–125.
26. Katahira K, Takahara T, Kwee TC, et al. Ultra-high-b-value diffusion-weighted MR imaging for the detection of prostate cancer: evaluation in 201 cases with histopathological correlation. Eur Radiol 2011;21:188–196.
27. Agarwal HK, Mertan FV, Sankineni S, et al. Optimal high b-value for diffusion weighted MRI in diagnosing high risk prostate cancers in the peripheral zone. J Magn Reson Imaging 2016 [Epub ahead of print].